RD
Dumont, Roxane Dina Caroline
Title | Published in | Access level | OA Policy | Year | Views | Downloads | |
---|---|---|---|---|---|---|---|
Seroprevalence of anti-SARS-CoV-2 antibodies and cross-variant neutralization capacity after the Omicron BA.2 wave in Geneva, Switzerland: a population-based study | The Lancet regional health. Europe | 2023 | 57 | 47 | |||
Occupational risk of SARS-CoV-2 infection and reinfection during the second pandemic surge: a cohort study | Occupational and environmental medicine | 2022 | 181 | 40 | |||
Seroprevalence of anti-SARS-CoV-2 antibodies 6 months into the vaccination campaign in Geneva, Switzerland, 1 June to 7 July 2021 | Euro surveillance | 2021 | 172 | 73 | |||
Risk of reinfection after seroconversion to Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2): A population-based propensity-score matched cohort study | Clinical Infectious Diseases | 2021 | 359 | 123 |